310 related articles for article (PubMed ID: 31676114)
1. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
[TBL] [Abstract][Full Text] [Related]
2. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
[TBL] [Abstract][Full Text] [Related]
3. Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based study.
Er LK; Chen L; Tsai YC; Lin YH; Huang WC; Chang CC; Lu CC; Huang KH; Chueh JS; Wu KD; Wu VC;
J Hypertens; 2020 Apr; 38(4):745-754. PubMed ID: 31764584
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation.
Kim KJ; Hong N; Yu MH; Lee H; Lee S; Lim JS; Rhee Y
Hypertension; 2021 Jun; 77(6):1964-1973. PubMed ID: 33866798
[TBL] [Abstract][Full Text] [Related]
7. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Amar L; Plouin PF; Steichen O
Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
[TBL] [Abstract][Full Text] [Related]
10. Long term outcome of Aldosteronism after target treatments.
Wu VC; Wang SM; Chang CH; Hu YH; Lin LY; Lin YH; Chueh SC; Chen L; Wu KD
Sci Rep; 2016 Sep; 6():32103. PubMed ID: 27586402
[TBL] [Abstract][Full Text] [Related]
11. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.
Pan CT; Liao CW; Tsai CH; Chen ZW; Chen L; Hung CS; Liu YC; Lin PC; Chang CC; Chang YY; Wu VC; Lin YH;
J Am Heart Assoc; 2020 Mar; 9(5):e013699. PubMed ID: 32070205
[TBL] [Abstract][Full Text] [Related]
12. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):51-59. PubMed ID: 29129576
[TBL] [Abstract][Full Text] [Related]
13. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
Amar L; Lorthioir A; Azizi M; Plouin PF
Eur J Endocrinol; 2015 Mar; 172(3):R125-9. PubMed ID: 25315875
[TBL] [Abstract][Full Text] [Related]
14. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments.
Wu VC; Wang SM; Huang KH; Tsai YC; Chan CK; Yang SY; Lin LY; Chang CC; Lu CC; Lin YH; Chen YM; Chueh JS
Eur J Endocrinol; 2021 Dec; 186(2):195-205. PubMed ID: 34851859
[TBL] [Abstract][Full Text] [Related]
15. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
[TBL] [Abstract][Full Text] [Related]
16. Risk of sepsis in patients with primary aldosteronism.
Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD;
Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
18. [Hyperaldosteronism].
Scholl UI
Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
[TBL] [Abstract][Full Text] [Related]
20. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
